Caroline J. Huang, PhD, is a Senior Science Policy Advisor in FDA’s Controlled Substances Program, Controlled Substances Initiatives team (CSP/CSI), in the Center for Drug Evaluation and Research. In this role, she oversees stakeholder engagement and strategic collaborations and communications across drug classes, as well as coordinating FDA’s controlled substances research portfolio. Prior to joining CSP/CSI in August 2020, Dr. Huang spent a year as a Staff Fellow in FDA’s Office of Women’s Health, where she covered issues related to COVID-19 and managed the team’s social science portfolio. She also completed a Bioethics Fellowship with the NIH Clinical Center, where she researched chronic pain and opioid use disorders and served as a bioethics consultant. She holds an SB in Brain and Cognitive Sciences from the Massachusetts Institute of Technology and a PhD (DPhil) in Public Health from the University of Oxford, where she was a Rhodes Scholar.